- Telehealth Visits
- Insurance plan information
David Fischer, MD, PhD
Neurology- Telehealth Visits
- Insurance plan information
David Fischer, MD, PhD
Neurology- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Behavioral Neurology & Neuropsychiatry, United Council for Neurologic Subspecialties
- Neurology, American Board of Psychiatry/Neurology-Psychiatry
Fellowship
- Behavioral Neurology, University of CA at San Francisco - Neurology GME
Residency
- Neurology, University of Alabama School of Medicine - GME
Internship
- Neurology, University of Alabama School of Medicine - GME
Degree
- MD, Michigan State Univ - College of Human Medicine
My expertise
Specialties
Locations
My research
Publications
Showing 1-6 of 20 reviews
- February 22, 20265 out of 5 Stars
Respectful, caring, knowledgeable. Exceptional overall visit.
- February 20, 20265 out of 5 Stars
Dr. Fischer was very patient and spent alot of time explaining and going through all our questions. Couldn't be happier!
- February 14, 20265 out of 5 Stars
I received the most exceptional care I have ever received from a doctor. He took the time to get to know me and thoroughly explained everything I needed to know. Dr Fischer is an exceptional doctor.
- October 22, 20255 out of 5 Stars
Dr. Fischer is very competent and kind, such a great combination!
- August 29, 20255 out of 5 Stars
Dr. Fischer was very professional and empathetic about all the questions I asked him. He gave me answers to each question. Also provided follow up on what I should do. I have total trust in his recommendations.
- August 8, 20255 out of 5 Stars
All my questions were answered in depth. I walked feeling very confident in his answers.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.